AstraZeneca PLC (AZN.L)

AZN.L on London Stock Exchange

3,758.50GBp
11:55am EDT
Price Change (% chg)

35.50p (+0.95%)
Prev Close
3,723.00p
Open
3,738.50p
Day's High
3,769.50p
Day's Low
3,735.00p
Volume
1,460,029
Avg. Vol
2,593,008
52-wk High
4,138.33p
52-wk Low
3,028.50p

AZN.L

Chart for AZN.L

About

AstraZeneca PLC (AstraZeneca) is a global biopharmaceutical company. AstraZeneca discovers, develops and commercializes prescription medicines for six areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and Inflammation. It has a range of medicines that includes treatments... (more)

Overall

Beta: 0.35
Market Cap (Mil.): £46,958.03
Shares Outstanding (Mil.): 1,261.30
Dividend: 116.80
Yield (%): 4.74

Financials

  AZN.L Industry Sector
P/E (TTM): 30.51 32.56 32.65
EPS (TTM): 1.22 -- --
ROI: 6.49 19.75 19.01
ROE: 10.89 20.45 19.78
Search Stocks

UPDATE 2-Danske Bank fined by Nasdaq OMX over AstraZeneca share trading

* Danske Bank to pay 500,000 SEK for breaching trading rules

10:26am EDT

Danske Bank fined by Nasdaq OMX over AstraZeneca share trading

- The Nasdaq OMX stock exchange in Stockholm has fined Danske Bank 500,000 Swedish crowns ($76,100) for breaching trading rules in a placing of orders for shares in drugs company AstraZeneca , it said on Wednesday.

8:10am EDT

AstraZeneca India unit sets floor price for stock delisting

April 11 - AstraZeneca Pharma India Ltd, a unit of British drugmaker AstraZeneca Plc, said on Friday the floor price for its delisting from the Indian stock exchanges had been set at 854.1 rupees a share.

11 Apr 2014

AstraZeneca digs into new Cambridge home with MRC drug deal

CAMBRIDGE, England - AstraZeneca, which will complete its move to Cambridge by 2016, is already putting down roots in the ecosystem of the university city as it seeks to revitalize its drug research.

30 Mar 2014

AstraZeneca digs into new Cambridge home with MRC drug deal

* AstraZeneca moving global HQ and R&D to Cambridge by 2016

30 Mar 2014

AstraZeneca raises bet on Japan by buying out Sumitomo

LONDON - AstraZeneca has raised its bet on Japan's drug market by buying out the remaining stake held by Sumitomo Chemical in its Japanese unit AstraZeneca K.K.

26 Mar 2014

AstraZeneca raises bet on Japan by buying out Sumitomo

LONDON, March 26 - AstraZeneca has raised its bet on Japan's drug market by buying out the remaining stake held by Sumitomo Chemical in its Japanese unit AstraZeneca K.K.

26 Mar 2014

Rivals race to develop new biotech asthma drugs

* GSK leads new wave with mepolizumab due for 2014 filing

18 Mar 2014

AstraZeneca sells British R&D site, to take $275 million charge

LONDON - AstraZeneca has agreed to sell its Alderley Park research site in northern England to a public-private partnership group as it moves drug discovery to a new global center in Cambridge.

12 Mar 2014

UPDATE 1-AstraZeneca sells British R&D site, to take $275 mln charge

LONDON, March 12 - AstraZeneca has agreed to sell its Alderley Park research site in northern England to a public-private partnership group as it moves drug discovery to a new global centre in Cambridge.

12 Mar 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00
Provider: Reuters Investment Profile
$20.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks